A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
出版年份 2023 全文链接
标题
A novel cuproptosis-related lncRNA signature predicts prognosis and therapeutic response in bladder cancer
作者
关键词
-
出版物
Frontiers in Genetics
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-01-04
DOI
10.3389/fgene.2022.1082691
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson’s disease
- (2021) Jianjian Dong et al. Cell Death & Disease
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
- (2021) D.J. McGrail et al. ANNALS OF ONCOLOGY
- Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer
- (2021) Yi Gou et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
- (2021) Wenxiao Jiang et al. Molecular Cancer
- A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer
- (2021) Yilin Yan et al. Frontiers in Cell and Developmental Biology
- Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance
- (2021) Maria V. Babak et al. Biomedicines
- Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis
- (2021) Xueying Ren et al. Redox Biology
- Development and Validation of Prognostic Model in Transitional Bladder Cancer Based on Inflammatory Response-Associated Genes
- (2021) Zhiwen Xie et al. Frontiers in Oncology
- Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations
- (2020) Anne Eaton et al. Clinical Trials
- Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
- (2020) Ya Luo et al. Frontiers in Oncology
- Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer
- (2020) Meng Zhou et al. BRIEFINGS IN BIOINFORMATICS
- Non-coding RNA in bladder cancer
- (2020) Yi Li et al. CANCER LETTERS
- LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p
- (2020) Longde Shen et al. ONCOLOGY REPORTS
- Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer
- (2020) Léo Aubert et al. Nature Communications
- Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
- (2020) Shan-Shan Yin et al. Frontiers in Immunology
- Identification of a TLR-Induced Four-lncRNA Signature as a Novel Prognostic Biomarker in Esophageal Carcinoma
- (2020) Jing Liu et al. Frontiers in Cell and Developmental Biology
- A cell-cycle signature classifier for pan-cancer analysis
- (2020) Neha Tabassum et al. ONCOGENE
- Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma
- (2020) Weige Zhou et al. Biomed Research International
- Bladder Cancer
- (2020) Andrew T. Lenis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
- (2020) Denis L. Jardim et al. CANCER CELL
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- The expanding landscape of ‘oncohistone’ mutations in human cancers
- (2019) Benjamin A. Nacev et al. NATURE
- lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA‐150
- (2019) Huarong Luo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes
- (2019) Peng Sun et al. BIOMEDICINE & PHARMACOTHERAPY
- The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies
- (2019) Lindsay Angus et al. NATURE GENETICS
- Antibody Drug Conjugates for Cancer Treatment
- (2019) Christine M. Walko et al. JAMA Oncology
- LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis
- (2019) Dong Fu et al. Aging-US
- Glutamine affects T24 bladder cancer cell proliferation by activating STAT3 through ROS and glutaminolysis
- (2019) Ningchuan Sun et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion
- (2019) Yuanyuan Jiang et al. CANCER LETTERS
- SnapShot: Bladder Cancer
- (2018) Carolyn Hurst et al. CANCER CELL
- ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
- (2018) Stefan Garczyk et al. PLoS One
- Elesclomol restores mitochondrial function in genetic models of copper deficiency
- (2018) Shivatheja Soma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis
- (2018) Elena V. Polishchuk et al. GASTROENTEROLOGY
- Tumor vesical: presente y futuro
- (2017) Roberto Hugo Martinez Rodriguez et al. MEDICINA CLINICA
- Defining the human copper proteome and analysis of its expression variation in cancers
- (2017) S. Blockhuys et al. Metallomics
- Targeted O -glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours
- (2017) Sofia Cotton et al. Molecular Oncology
- Copper import in Escherichia coli by the yersiniabactin metallophore system
- (2017) Eun-Ik Koh et al. Nature Chemical Biology
- Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer
- (2017) Divya Sahu et al. Cancer Medicine
- Immunotherapy in Bladder Cancer
- (2016) Monali Vasekar et al. Current Molecular Pharmacology
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
- (2013) Steven J. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Bioavailable copper modulates oxidative phosphorylation and growth of tumors
- (2013) S. Ishida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
- (2013) Paul Blanche et al. STATISTICS IN MEDICINE
- Variation of Urinary and Serum Trace Elements (Ca, Zn, Cu, Se) in Bladder Carcinoma in China
- (2012) Kun-Feng Guo et al. Asian Pacific Journal of Cancer Prevention
- TP53 Mutations in Nonsmall Cell Lung Cancer
- (2011) Akira Mogi et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
- (2010) Ilaria Marigo et al. IMMUNITY
- The comparative study of serum iron, copper, and zinc levels between bladder cancer patients and a control group
- (2009) Hamid Mazdak et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Determining urinary trace elements (Cu, Zn, Pb, As, and Se) in patients with bladder cancer
- (2009) Chang-Ni Lin et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now